Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in the Treatment of Pediatric Alopecia Areata
NCT05866562Phase 2Recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2024
- Primary completion
- Mar 2029
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in alopecia areata, sponsored by Icahn School of Medicine at Mount Sinai. Started Jul 2024; status: recruiting.
02
Drugs
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT05866562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05866562.